Arnold Mark Einhorn

What was reported

$31,155.05

in general payments reported to CMS, 2019-2025 · $2,794 in 2025

The $2,794 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Who reported paying

General payments only, top 6 by amount.

• Boehringer Ingelheim Pharmaceuticals, INC. $12,548.60
• Astellas Pharma US INC $8,850.36
• Kestra Medical Technology Services, INC. $2,900.86
• Biotronik INC. $2,502.22
• Boston Scientific Corporation $557.98
• Medtronic, INC. $512.10

Drugs and devices associated with these payments

Assure Wcd Biomonitor Repatha Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter Corevalve Evolut R Wainua Leqvio Amvia Edge Camzyos Watchman Access System Lux-Dx Insertable Cardiac Monitor Onpattro

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

• I saw Arnold Einhorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?
• Is there a generic or alternative to this medication, and would it work as well for me?
• What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.